| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $992.1M | -2.3% |
| Cost of Revenue | $799.4M | +3.1% |
| Gross Profit | $192.7M | -19.8% |
| R&D Expense | $40.3M | +2.9% |
| SG&A Expense | $57.1M | -19.3% |
| Operating Income | -$13.5M | -139.2% |
| Interest Expense | $7.6M | +92.4% |
| Pre-tax Income | -$18.6M | -27.8% |
| Income Tax | $6.0M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $105.6M | -76.8% |
| Short-term Investments | $166.9M | — |
| Accounts Receivable | $181.3M | -6.0% |
| Current Assets | $500.5M | -26.0% |
| Total Assets | $781.1M | -1.9% |
| Current Liabilities | $300.1M | +4.0% |
| Long-term Debt | $236.0M | +0.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $3.8M | -93.3% |
| Capital Expenditures | $13.4M | +37.3% |
| Investing Cash Flow | -$317.9M | -1481.5% |
| Financing Cash Flow | -$31.7M | -109.7% |
| Free Cash Flow | -$9.6M | -120.3% |
| +123.5% |
| Net Income | -$24.6M | -323.6% |
| EPS (Basic) | -$0.44 | -241.9% |
| EPS (Diluted) | -$0.44 | -320.0% |
| Total Liabilities |
| $563.4M |
| +4.5% |
| Stockholders' Equity | $217.8M | -15.2% |